超滤法分级和纯化蛋白质的现状和前景(英文)

超滤法具有高产率、低成本、容易放大等显著优点,但其低选择性一直限制其在生物蛋白制品的分级和纯化中的应用。本文总结和分析了超滤法用于蛋白质分级和纯化的近期研究成果,对其低选择性的原因进行了分析,提出并论证了提高超滤选择性的技术途径。     

Symmetry perception in an insect

Symmetrical visual patterns have a salient status in human perception, as evinced by their prevalent occurrence in art, and also in animal perception, where they may be an indicator of phenotypic and genotypic quality. Symmetry perception has been demonstrated in humans, birds, dolphins and apes. Here we show that bees trained to discriminate bilaterally symmetrical from non-symmetrical patterns learn the task and transfer it appropriately to novel stimuli, thus demonstrating a capacity to detect and generalize symmetry or asymmetry. We conclude that bees, and possibly flower-visiting insects in general, can acquire a generalized preference towards symmetrical or, alternatively, asymmetrical patterns depending on experience, and that symmetry detection is preformed or can be learned as perceptual category by insects, because it can be extracted as an independent visual pattern feature. Bees show a predisposition for learning and generalized symmetry because, if trained to it, they choose it more frequently, come closer to and hover longer in front of the novel symmetrical stimuli than the bees trained for asymmetry do for the novel asymmetrical stimuli. Thus, even organisms with comparatively small nervous systems can generalize about symmetry, and favour symmetrical over asymmetrical patterns.     

A massive phytoplankton bloom induced by an ecosystem-scale iron fertilization experiment in the equatorial Pacific Ocean

The seeding of an expanse of surface waters in the equatorial Pacific Ocean with low concentrations of dissolved iron triggered a massive phytoplankton bloom which consumed large quantities of carbon dioxide and nitrate that these microscopic plants cannot fully utilize under natural conditions. These and other observations provide unequivocal support for the hypothesis that phytoplankton growth in this oceanic region is limited by iron bioavailability.     

Frederick Pavy (1829-1911) and his opposition to the glycogenic theory of Claude Bernard

For more than 50 years the Guy's Hospital physician Frederick Pavy (1829-1911) attempted to discredit the theory of his erstwhile teacher, Claude Bernard, that liver glycogen was broken down to supply sugar to the systemic circulation. His opposition was driven by his clinical perceptions and was based on two assumptions: the first was that the kidney was a simple filter through which small molecules would diffuse, so that sugar had to be prevented from reaching the systemic circulation. For Pavy, the liver was the barrier. The second was teleological: he could not believe that nature would operate in what he saw as a defective way, i.e. converting sugar into glycogen and then back again. At the beginning of his long working life Pavy regarded himself as a physiologist and was critical of the stagnancy of English physiology which was kept afloat by amateurs like himself in whatever time they could spare from busy private practice. At the end he came to see his own view of carbohydrate metabolism as symbolic of the schism between responsible clinicians (himself) and irresponsible daydreaming physiologists (his opponents).     

今年的“厄尔尼诺”有可能成为世纪之最

近6个月来,太平洋的热带水域一直在扩散,从国际日期变更线蔓延到了南美洲沿海。气象学家对此一直非常关注,密切跟踪着它的变化,因为这就是能够在大气和海洋中翻云覆雨的"厄尔尼诺"现象。而且,有迹象表明,眼下的"厄尔尼诺"现象正在积蓄力量,有可能在未来的几个月内给世界天气带来巨大的变化。热带风暴频频造访墨西哥、智利和秘鲁,使之大雨不断,澳大利亚和印度尼西亚干旱少雨......科学家认为,种种迹象表明,强大的"厄尔尼诺"已经左右了世界天气。本年度的"厄尔尼诺"很可能使本世纪所有的"厄尔尼诺"相形见细。它对热带洋面的影响范…     

Interferon therapy: side effect scare hits French trials

The French Ministry of Health, acting on the advice of its scientific council, has halted clinical trials of interferon in cancer patients after four out of eleven recipients died of myocardial infarctions. Trials are expected to resume after the domestically produced drug stock is repurified and successfully retested. It has been suggested that council oversight should be extended to imported interferon and other experimental drugs which are now being used in human trials without the Ministry's control or knowledge.